Licensing instead of fueling: Glutamine synthetase promotes mitotic progression via a non-metabolic mechanism
Visualized Cancer Medicine · 2023
DOI: 10.1051/vcm/2022009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Visualized Cancer Medicine, 2023. Verfasst von Jiang-Sha Zhao und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A recent report published in Nature Metabolism identified that glutamine synthetase (GS), the only enzyme in mammals to produce glutamine from glutamate, can directly control cancer cell mitosis by governing the APC/C complex via a metabolism-independent mechanism. It reported that GS can directly interact with the nuclear pore protein NUP88 to abolish its binging with CDC20, therefore licensing the activation of APC/C CDC20 to permit proper metaphase to anaphase transition of mitosis. These findings illustrated a dual-function mode of action of GS in cancer cells, in which GS’s metabolic and non-metabolic functions coordinate with the concentration change of glutamine in the tumor microenvironment (TME) to ensure cell survival or proliferation, respectively. These findings revealed the multi-faceted roles of glutamine synthetase in tumor development and underscored the potential to target non-canonical functions of glutamine synthetase for cancer treatment.
Zitieren
APA
Zhao, J., Yang, J., Lu, Z., & Feng, Y. (2023). Licensing instead of fueling: Glutamine synthetase promotes mitotic progression via a non-metabolic mechanism. Visualized Cancer Medicine. https://doi.org/10.1051/vcm/2022009
Vancouver
Zhao J, Yang J, Lu Z, Feng Y. Licensing instead of fueling: Glutamine synthetase promotes mitotic progression via a non-metabolic mechanism. Visualized Cancer Medicine. 2023. doi:10.1051/vcm/2022009
BibTeX
@article{Zhao2023,
author = {Zhao, Jiang-Sha and Yang, Jing and Lu, Zhimin and Feng, Yu-Xiong},
title = {Licensing instead of fueling: Glutamine synthetase promotes mitotic progression via a non-metabolic mechanism},
journal = {Visualized Cancer Medicine},
year = {2023},
doi = {10.1051/vcm/2022009}
}
EUVIMED